181 related articles for article (PubMed ID: 28956700)
1. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.
Echecopar-Sabogal J; D'Angelo-Piaggio L; Chanamé-Baca DM; Ugarte-Gil C
Int J STD AIDS; 2018 Apr; 29(5):443-452. PubMed ID: 28956700
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.
Justman JE; Benning L; Danoff A; Minkoff H; Levine A; Greenblatt RM; Weber K; Piessens E; Robison E; Anastos K
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):298-302. PubMed ID: 12626890
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.
Wu PY; Hung CC; Liu WC; Hsieh CY; Sun HY; Lu CL; Wu H; Chien KL
J Antimicrob Chemother; 2012 Apr; 67(4):1001-9. PubMed ID: 22232517
[TBL] [Abstract][Full Text] [Related]
4. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.
Barbaro G; Di Lorenzo G; Cirelli A; Grisorio B; Lucchini A; Hazra C; Barbarini G
Clin Ther; 2003 Sep; 25(9):2405-18. PubMed ID: 14604740
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.
Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome among HIV infected patients: A comparative cross sectional study in northwestern Nigeria.
Muhammad FY; Gezawa ID; Uloko A; Yakasai AM; Habib AG; Iliyasu G
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S523-S529. PubMed ID: 28410829
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review.
Silva BF; Peixoto G; da Luz SR; de Moraes S; Peres SB
HIV Med; 2019 Aug; 20(7):429-438. PubMed ID: 31006976
[TBL] [Abstract][Full Text] [Related]
9. Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV-infected patients? A meta-analysis.
Nduka CU; Stranges S; Kimani PK; Sarki AM; Uthman OA
Diabetes Metab Res Rev; 2017 Sep; 33(6):. PubMed ID: 28437854
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.
Wand H; Calmy A; Carey DL; Samaras K; Carr A; Law MG; Cooper DA; Emery S;
AIDS; 2007 Nov; 21(18):2445-53. PubMed ID: 18025881
[TBL] [Abstract][Full Text] [Related]
11. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
Rebeiro PF; Jenkins CA; Bian A; Lake JE; Bourgi K; Moore RD; Horberg MA; Matthews WC; Silverberg MJ; Thorne J; Mayor AM; Lima VD; Palella FJ; Saag MS; Althoff KN; Gill MJ; Wong C; Klein MB; Crane HM; Marconi VC; Shepherd BE; Sterling TR; Koethe JR
Clin Infect Dis; 2021 Oct; 73(7):e2234-e2242. PubMed ID: 32936919
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
Todowede OO; Mianda SZ; Sartorius B
Syst Rev; 2019 Jan; 8(1):4. PubMed ID: 30606249
[TBL] [Abstract][Full Text] [Related]
13. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
[TBL] [Abstract][Full Text] [Related]
14. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study.
Lin SP; Wu CY; Wang CB; Li TC; Ko NY; Shi ZY
Medicine (Baltimore); 2018 Sep; 97(36):e12268. PubMed ID: 30200166
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome in HIV-patients in Antiretroviral Therapy.
Vargas-Pacherrez D; Cotrim HP; Pires L; Cunha V; Coelho V; Brites C; Daltro C
Curr HIV Res; 2020; 18(6):388-395. PubMed ID: 32516101
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome associated with HIV and highly active antiretroviral therapy.
Barbaro G; Iacobellis G
Curr Diab Rep; 2009 Feb; 9(1):37-42. PubMed ID: 19192423
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
[TBL] [Abstract][Full Text] [Related]
18. Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART.
Uccelli MC; Torti C; Lapadula G; Labate L; Cologni G; Tirelli V; Moretti F; Costarelli S; Quiros-Roldan E; Carosi G
Ann Nutr Metab; 2006; 50(3):247-52. PubMed ID: 16508252
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.
Brown TT; Qaqish RB
AIDS; 2006 Nov; 20(17):2165-74. PubMed ID: 17086056
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor-associated QT interval prolongation.
Hunt K; Hughes CA; Hills-Nieminen C
Ann Pharmacother; 2011 Dec; 45(12):1544-50. PubMed ID: 22128044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
